Search results for " biologic" in Articles / App Notes
								 					Article
				
				Regulatory Challenges in the QbD Paradigm
								This model is especially evident in FDA's Center for Drug Evaluation and Research (CDER) as used for therapeutic biological products, such as proteins and monoclonal antibodies. These products were tr…								
								 					Article
				
				Pharma Investments Reflect Key Industry Trends
								First is the shift to biologic-based drugs, which has occurred along with a dramatic increase in the productivity, mainly in terms of much higher titers, of biopharmaceutical processes. “While demand …								
								 					Article
				
				Elucidating Biosimilars Characterization
								The growth corresponds to a 20% increase from last year’s figures and accounts for approximately 2% of the overall biologics market. Although narrowly focused on only a small number of therapy areas a…								
								 					Article
				
				Reimagining Affordable Biosimilars
								With an anticipated valuation of over $200 billion by 2022, this popularity of protein-based biologics can be attributed to their unique target specificity in protein–protein interactions for the trea…								
								 					Article
				
				Microbiological Testing: Time is of the Essence
								Conventional protocols no longer suitable for traditional biologics
	
	Microbiology testing of pharmaceutical products is performed with a view to detection, enumeration, and identification of microbi…								
								 					Article
				
				Preclinical Evaluation of Product Related Impurities and Variants
								Not all biologics can be subjected to a uniform panel of tests owing to their differences in their modes of action as well as their inherent biological/chemical complexities (8). In this 38th article …								
								 					Article
				
				Managing Residual Impurities During Downstream Processing
								Challener
	Manufacture of protein and other biologic drug substances via cell culture or fermentation occurs with the natural, simultaneous production of other unwanted materials, particularly host-…								
								 					Article
				
				Unifying Continuous Biomanufacturing Operations
								The most efficient upstream processing systems in biologics manufacturing seek to mimic the body’s treatment of cells, so a constant level of incoming nutrients and outgoing waste products is necessar…								
								 					Article
				
				Reviewing the Importance of Biosimilarity and Interchangeability
								The importance of biosimilar products is tied to the push for more affordable, accessible biological treatments. However, bringing a biosimilar to market has strict challenges because the biosimilar d…								
								 					Article
				
				The Importance of Partnering for Bioanalytical Studies
								By Feliza Mirasol
	
	
		Bioanalytical studies are an important aspect in biologic drug development because data from these studies are needed to define the characteristics of potential new biologic …